Alternative medicines for AIDS in resource-poor settings: Insights from exploratory anthropological studies in Asia and Africa

Abstract

The emergence of alternative medicines for AIDS in Asia and Africa was discussed at a satellite symposium and the parallel session on alternative and traditional treatments of the AIDSImpact meeting, held in Marseille, in July 2007. These medicines are heterogeneous, both in their presentation and in their geographic and cultural origin. The sessions focused on the role of these medications in selected resource poor settings in Africa and Asia now that access to anti-retroviral therapy is increasing. The aims of the sessions were to (1) identify the actors involved in the diffusion of these alternative medicines for HIV/AIDS, (2) explore uses and forms, and the way these medicines are given legitimacy, (3) reflect on underlying processes of globalisation and cultural differentiation, and (4) define priority questions for future research in this area. This article presents the insights generated at the meeting, illustrated with some findings from the case studies (Uganda, Senegal, Benin, Burkina Faso, China and Indonesia) that were presented. These case studies reveal the wide range of actors who are involved in the marketing and supply of alternative medicines. Regulatory mechanisms are weak. The efficacy claims of alternative medicines often reinforce a biomedical paradigm for HIV/AIDS, and fit with a healthy living ideology promoted by AIDS care programs and support groups. The AIDSImpact session concluded that more interdisciplinary research is needed on the experience of people living with HIV/AIDS with these alternative medicines, and on the ways in which these products interact (or not) with anti-retroviral therapy at pharmacological as well as psychosocial levels. Alternative medicines for AIDS in resource-poor settings: insights from exploratory anthropological studies in Asia and AfricaA large number of new treatments offered to people living with HIV/AIDS (PLWA) have appeared over the last fifteen years in the therapeutic domain of AIDS. These medicines are particularly heterogeneous, both in their presentation and in their geographic and cultural origin. They constitute a group of products with a therapeutic aim that occupies a space between the customary traditional, popular and biomedical sectors of health care [1]. These products often mix reference to biomedicine and science

Perceptions of the use of complementary therapy and Siddha medicine among rural patients with HIV/AIDS: a case study from India

“…Therefore, although antiretroviral implementation programmes continue to expand, it is important to determine whether the knowledge, attitudes and treatment practices of HIV-infected individuals and their healthcare providers are aligned with current treatment recommendations. Failing to acknowledge and address local beliefs and healthcare practices may compromise the long-term success of HIV treatment programmes (Sharma, 2004;Thomas et al, 2007;Hardon et al, 2008).…”

Attitudes Toward Antiretroviral Therapy and Complementary and Alternative Medicine in Chinese Patients Infected With HIV

“…One study described nurses in Uganda using a traditional, nurse-prepared ointment on PLWH as an alternative medication for skin problems because they “know it works” (Hardon et al, 2008). CAM has also been used to treat the psychological and physical effects of illness and the side effects of ART (Kaufman & Gregory, 2007).…”

Magic Power: changing gender dynamics and sex-enhancement practices among youths in Makassar, Indonesia

“…Idrus 2009). More recently, producers have begun mixing herbs and synthetic chemicals in 'neotraditional' products, among them energy drinks and 'herbal Viagras' marketed for sexual dysfunction and enhancement (Lyon 2005;Hardon et al 2008). Indonesian neotraditional products for sexual enhancement and hygiene can now also be found across Southeast Asia as migrant workers seek out their preferred brands in the supermarkets of Hong Kong and Singapore.…”